MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$63,104
Net Income
-$1,268,142
Net Profit Margin
-2009.61%
EPS
-$1.22
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net revenue
63,104
28,353
379*
1,941
Cost of revenue
50,818
22,603
1,379*
1,057
Inventory write off
42,372
-
-
-
Gross margin
-30,086
5,750
-1,000
884
General and administrative (including stock based compensation of 157,500, 0, 157,500 and 14,131,250, respectively)
970,211
1,020,457
1,655,199
512,993
Research and development
233,482
296,723
100,035
207,899
Sales and marketing
1,215,025
334,739
93,190
425,489
Merger and acquisition expenses
229,418
-
-
-
Total operating expenses
2,648,136
1,651,919
1,848,424
1,146,381
Loss from operations
-2,678,222
-1,646,169
-1,849,424
-1,145,497
Interest income
56,676
5,009
-
-
Interest expense
-
1,595,315
7,032,907.5*
1,480,058
Change in fair value of derivative liabilities and convertible notes
-275
251,807
3,470,145
775,062
Initial recognition of forward purchase liability
-
-
-23,765.5*
-
Loss on extinguishment of debt
-
238,224
-
-
Loss (gain) on extinguishment of debt
1,353,679
-
728,218*
-
Total other expense, net
1,410,080
-1,576,723
-2,858,310
-704,996
Loss before provision for income taxes
-1,268,142
-3,222,892
-4,707,734
-
Net loss
-1,268,142
-3,222,892
-4,707,734
-1,850,493
Basic EPS
-1.22
-20.57
-
-0.04
Diluted EPS
-1.22
-20.57
0.101
-0.04
Basic Average Shares
1,037,874
156,685
-46,536,058
49,525,970
Diluted Average Shares
1,037,874
156,685
-46,536,058
49,525,970
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$1,268,142
(35.99%↑ Y/Y)
Loss (gain) on
extinguishment of debt
$1,353,679
(471.78%↑ Y/Y)
Interest income
$56,676
Loss before
provision for income taxes
-$1,268,142
Total other expense,
net
$1,410,080
(219.36%↑ Y/Y)
Change in fair value of
derivative liabilities and...
-$275
(99.90%↑ Y/Y)
Loss from operations
-$2,678,222
Total operating
expenses
$2,648,136
(231.06%↑ Y/Y)
Gross margin
-$30,086
Net revenue
$63,104
Sales and marketing
$1,215,025
(2267.96%↑ Y/Y)
General and
administrative (including...
$970,211
(145.19%↑ Y/Y)
Research and development
$233,482
(-33.84%↓ Y/Y)
Merger and acquisition
expenses
$229,418
Cost of revenue
$50,818
Inventory write off
$42,372
Buy us a coffee
Aspire Biopharma Holdings, Inc. (ASBPW)
Aspire Biopharma Holdings, Inc. (ASBPW)